Selected Start-Ups (04/2011)
In Vivo briefly describes these recently founded companies: Abcodia, Blueprint Medicines, Dipexium Pharmaceuticals, ImmusanT, International Cardio and N8 Medical.
You may also be interested in...
South Korean pharma HK inno.N’s $500m IPO has drawn strong interest with subscriptions from institutional investors marking a record high. The IPO should help it speed up development of cell and gene therapies and beef up its vaccines business.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
For the second quarter of 2021, biopharmas brought in an aggregate $42.2bn in financing and device company fundraising totaled $3.1bn; while in vitro diagnostic firms and research tools players raised $5bn.